Published in Biochem Soc Trans on January 01, 1983
New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges. Parkinsons Dis (2011) 0.76
White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia. Schizophr Res Treatment (2011) 0.75
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature (1989) 4.69
Prion dementia without characteristic pathology. Lancet (1990) 3.66
Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ (1994) 3.33
The emperors of the schizophrenia polygene have no clothes. Psychol Med (2008) 3.31
Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (1976) 3.14
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry (1990) 2.67
Anticipation in Huntington's disease is inherited through the male line but may originate in the female. J Med Genet (1988) 2.37
Antecedents of schizophrenia and affective illness. Obstetric complications. Br J Psychiatry (1995) 2.25
Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet (1989) 2.11
Molecular pathology of schizophrenia: more than one disease process? Br Med J (1980) 2.11
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet (1998) 2.07
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology (Berl) (1995) 2.07
Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sample. BMJ (1991) 2.03
Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis. Lancet (1989) 1.97
Influenza and schizophrenia. Br J Psychiatry (1996) 1.93
Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain (1992) 1.86
The dementia of dementia praecox. Acta Psychiatr Scand (1978) 1.79
The Northwick Park electroconvulsive therapy trial. Lancet (1981) 1.79
Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet (1994) 1.78
Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry (1986) 1.74
Prenatal exposure to influenza as a cause of schizophrenia. There are inconsistencies and contradictions in the evidence. Br J Psychiatry (1994) 1.73
Schizophrenic patients discharged from hospital--a follow-up study. Br J Psychiatry (1984) 1.71
Functional integration of striatal allografts in a primate model of Huntington's disease. Nat Med (1998) 1.71
Dose-dependent effect of dietary meat on endogenous colonic N-nitrosation. Carcinogenesis (2001) 1.70
Aminoacid polymorphism in human prion protein and age at death in inherited prion disease. Lancet (1991) 1.67
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain (1992) 1.66
The myth of maternal transmission of spongiform encephalopathy. BMJ (1995) 1.63
The continuum of psychosis and its implication for the structure of the gene. Br J Psychiatry (1986) 1.60
Adult psychosis, common childhood infections and neurological soft signs in a national birth cohort. Br J Psychiatry (2002) 1.56
Codon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet (1990) 1.52
Analysis of time-resolved fluorescence anisotropy decays. Biophys J (1984) 1.49
Who benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park trials. Br J Psychiatry (1992) 1.49
Dopamine is a monoamine oxidase B substrate in man. Nature (1977) 1.48
Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: A postmortem study. Am J Psychiatry (2000) 1.48
CNS amyloid proteins in neurodegenerative diseases. Neurology (1988) 1.47
Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet (1978) 1.47
Experimental transmission of an autosomal dominant spongiform encephalopathy: does the infectious agent originate in the human genome? Br Med J (Clin Res Ed) (1985) 1.47
The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain (1999) 1.47
Prion protein: a different concept of replication. Trends Neurosci (1993) 1.46
Precursors of psychosis as pointers to the Homo sapiens-specific mate recognition system of language. Br J Psychiatry (1998) 1.43
The two-syndrome concept: origins and current status. Schizophr Bull (1985) 1.42
Twin studies of psychosis and the genetics of cerebral asymmetry. Br J Psychiatry (1999) 1.42
Urinary chromatographic profiles in schizophrenia. Biol Psychiatry (1990) 1.42
Prion-protein immunoreactivity in human transmissible dementias. N Engl J Med (1986) 1.42
Chromosome Workshops 1998: current state of psychiatric linkage. Am J Med Genet (1999) 1.41
Small intestine permeability in schizophrenia. Br J Psychiatry (1989) 1.41
Influenza and schizophrenia. Br J Psychiatry (1997) 1.40
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Study so far provides no evidence for maternal and horizontal transmission. BMJ (1996) 1.37
The Northwick Park Study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission. Br J Psychiatry (1986) 1.36
Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol (1994) 1.31
Schizophrenia and sex chromosome anomalies. Schizophr Bull (1994) 1.29
Left brain, retrotransposons, and schizophrenia. Br Med J (Clin Res Ed) (1986) 1.29
A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry (1986) 1.27
Retention of an associative behavioral change in Hermissenda. Science (1978) 1.27
Intracranial self-stimulation with electrodes in the region of the locus coeruleus. Brain Res (1972) 1.27
Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm (Vienna) (2005) 1.26
Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry (1980) 1.25
Role of tryptaminergic mechanisms in the elements of the behavioural syndrome evoked by tryptophan and a monoamine oxidase inhibitor [proceedings]. Br J Pharmacol (1977) 1.22
Possible virus in schizophrenia and some neurological disorders. Lancet (1979) 1.21
Familial cerebral amyloidosis and spongiform encephalopathy. J Neurol Neurosurg Psychiatry (1982) 1.19
Neurochemical changes following kainic acid lesions of the nucleus accumbens: implications for a GABAergic accumbal-ventral tegmental pathway. Life Sci (1978) 1.19
Associative behavioral modification in hermissenda: cellular correlates. Science (1980) 1.19
Increased dopamine-receptor sensitivity in schizophrenia. Lancet (1978) 1.15
Stimulus specificity in the human visual system. Vision Res (1973) 1.14
Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. Br J Pharmacol (1994) 1.13
An analysis of the learning deficit following hyoscine administration to man. Br J Pharmacol (1973) 1.13
Location of neuronal tangles in somatostatin neurones in Alzheimer's disease. Nature (1985) 1.12
A critical evaluation of monkey models of amnesia and dementia. Brain Res Brain Res Rev (1991) 1.11
Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem (1989) 1.11
Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J (Clin Res Ed) (1981) 1.11
Presymptomatic detection or exclusion of prion protein gene defects in families with inherited prion diseases. Am J Hum Genet (1991) 1.10
Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. Int J Exp Pathol (1993) 1.10
Pick's disease is associated with mutations in the tau gene. Ann Neurol (2000) 1.10